Authors: Kazakova A; Laboratory of Translational Cellular and Molecular Biomedicine, National Research Tomsk State University, Tomsk 634050, Russian Federation., Sudarskikh T; Laboratory of Translational Cellular and Molecular Biomedicine, National Research Tomsk State University, Tomsk 634050, Russian Federation., Kovalev O; Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk 634009, Russian Federation., Kzhyshkowska J; Laboratory of Translational Cellular and Molecular Biomedicine, National Research Tomsk State University, Tomsk 634050, Russian Federation., Larionova I; Laboratory of Translational Cellular and Molecular Biomedicine, National Research Tomsk State University, Tomsk 634050, Russian Federation.

Source: International journal of oncology [Int J Oncol] 2023 Feb; Vol. 62 (2). Date of Electronic Publication: 2023 Jan 20.

Publication Type: Journal Article; Review

Journal Info: Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9306042 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1791-2423 (Electronic) Linking ISSN: 10196439 NLM ISO Abbreviation: Int J Oncol Subsets: MEDLINE

Authors: Kazakova E; Laboratory of Translational Cellular and Molecular Biomedicine, Tomsk State University, Tomsk, Russia.; Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia., Rakina M; Laboratory of Translational Cellular and Molecular Biomedicine, Tomsk State University, Tomsk, Russia.; Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia., Sudarskikh T; Laboratory of Translational Cellular and Molecular Biomedicine, Tomsk State University, Tomsk, Russia., Iamshchikov P; Laboratory of Translational Cellular and Molecular Biomedicine, Tomsk State University, Tomsk, Russia.; Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia., Tarasova A; Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia., Tashireva L; Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia., Afanasiev S; Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia., Dobrodeev A; Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia., Zhuikova L; Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia., Cherdyntseva N; Laboratory of Translational Cellular and Molecular Biomedicine, Tomsk State University, Tomsk, Russia.; Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia.; Laboratory of Genetic Technologies, Siberian State Medical University, Tomsk, Russia., Kzhyshkowska J; Laboratory of Translational Cellular and Molecular Biomedicine, Tomsk State University, Tomsk, Russia.; Laboratory of Genetic Technologies, Siberian State Medical University, Tomsk, Russia.; Institute of Transfusion Medicine and Immunology, Institute for Innate Immunoscience (MI3), Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.; German Red Cross Blood Service Baden-Württemberg - Hessen, Mannheim, Germany., Larionova I; Laboratory of Translational Cellular and Molecular Biomedicine, Tomsk State University, Tomsk, Russia.; Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia.; Laboratory of Genetic Technologies, Siberian State Medical University, Tomsk, Russia.

Source: Frontiers in oncology [Front Oncol] 2023 Feb 21; Vol. 13, pp. 1058337. Date of Electronic Publication: 2023 Feb 21 (Print Publication: 2023).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE